Trilipix ANDA Spurs Abbott, Fournier To Sue Impax

Law360, New York (March 16, 2010, 4:02 PM EDT) -- Abbott Laboratories and Fournier Laboratories Ireland Ltd. have fired off a patent infringement complaint against Impax Laboratories Inc., claiming that the generic-drug maker infringed their patent by applying to market its own version of the companies' cholesterol drug.

After Impax notified the plaintiffs in January that it had filed an abbreviated new drug application with the U.S. Food and Drug Administration for a generic version of Trilipix, Abbott and Fournier hit back by filing a complaint Friday in the U.S. District Court for the District of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.